If approved, Valneva’s shot could be the first approved for chikungunya, a virus transmitted by mosquitoes with similar symptoms to dengue and Zika, including severe joint pain that can last years.
First Vaccine For Chikungunya—An Emerging Mosquito-Borne Threat—Nears After Promising Trial Results
